Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD Clinical Trial

— COPD-HOME  

Official title:

Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00702078
• Other study ID #: 17417
• Status: Completed
• Phase: N/A
• First received: June 19, 2008
• Last updated: January 9, 2017
• Start date: April 2008
• Est. completion date: December 2015

Study information

• Verified date: January 2017
• Source: St. Olavs Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Norwegian Social Science Data Services
• Study type: Interventional

Clinical Trial Summary

We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD.

The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 172
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 95 Years

Eligibility

Inclusion Criteria:

• clinical diagnosis of COPD (III-IV)

• receive help from homecare nurse

• not suffering from any other serious disease, with expected lifespan less than 6 months

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• COPD
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• closer collaboration between hospital and primary healthcare system
Follow-up from the hospital and the primary healthcare in cooperation
• usual care
follow-up according to todays best practice

Locations

Country	Name	City	State
Norway	Dept. of Lung Diseases, St.Olavs Hospital	Trondheim

Sponsors (2)

Lead Sponsor	Collaborator
St. Olavs Hospital	Community Health Network

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Titova E, Salvesen Ø, Bentsen SB, Sunde S, Steinshamn S, Henriksen AH. Does an Integrated Care Intervention for COPD Patients Have Long-Term Effects on Quality of Life and Patient Activation? A Prospective, Open, Controlled Single-Center Intervention Stud — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of hospitalizations		2011	No
Secondary	quality of life		2011	No
Secondary	lung function		2011	No
Secondary	use of medication		2011	No
Secondary	cost-effectiveness		2011	No